Literature DB >> 10780943

Oxoproline kinetics and oxoproline urinary excretion during glycine- or sulfur amino acid-free diets in humans.

C C Metges1, Y M Yu, W Cai, X M Lu, S Wong, M M Regan, A Ajami, V R Young.   

Abstract

L-5-oxoproline (L-5-OP) is an intermediate in glutathione synthesis, possibly limited by cysteine availability. Urinary 5-OP excretion has been proposed as a measure of glycine availability. We investigated whether 5 days of dietary sulfur amino acid (SAA-free) or glycine (Gly-free) restriction affects plasma kinetics of 5-OP and urinary excretion of L- and D-5-OP in 6 healthy men. On day 6, L-5-[1-(13)C]oxoproline and [3,3-(2)H(2)]cysteine were infused intravenously for 8 h (3 h fast/5 h fed). In a control study (adequate amino acid mixture), plasma oxoproline fluxes were 37.8 +/- 13.8 (SD) and 38.4 +/- 14.8 micromol x kg(-1) x h(-1); oxidation accounted for 85% of flux. Cysteine flux was 47.9 +/- 8.5 and 43.2 +/- 8.5 micromol x kg(-1) x h(-1) for fast and fed phases, respectively. Urinary excretion of L- and D-5-OP was 70 +/- 34 and 31.1 +/- 13.3 micromol/mmol creatinine, respectively, during days 3-5, and 46.4 +/- 13.9 and 22.4 +/- 8.3 micromol/mmol over the 8-h tracer study. The 5-OP flux for the Gly-free diet was higher (P = 0. 018) and tended to be higher for the SAA-free diet (P = 0.057) when compared with the control diet. Oxidation rates were higher on the Gly-free (P = 0.005) and SAA-free (P = 0.03) diets. Cysteine fluxes were lower on the the Gly-free (P = 0.01) and the SAA-free diets (P = 0.001) compared with the control diet. Rates of L-5-OP excretion were unchanged by withdrawal of SAA or Gly for 5 days but increased on day 6 (P = 0.005 and P = 0.019, respectively). Thus acute changes in the dietary availability of SAA and Gly alter oxoproline kinetics and urinary 5-OP excretion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10780943     DOI: 10.1152/ajpendo.2000.278.5.E868

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  7 in total

Review 1.  Emerging regulatory paradigms in glutathione metabolism.

Authors:  Yilin Liu; Annastasia S Hyde; Melanie A Simpson; Joseph J Barycki
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

2.  Blood glutathione synthesis rates in healthy adults receiving a sulfur amino acid-free diet.

Authors:  J Lyons; A Rauh-Pfeiffer; Y M Yu; X M Lu; D Zurakowski; R G Tompkins; A M Ajami; V R Young; L Castillo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

3.  Long-term patterns of urinary pyroglutamic acid in healthy humans.

Authors:  Richard S Lord
Journal:  Physiol Rep       Date:  2016-02

4.  Urinary metabolic insights into host-gut microbial interactions in healthy and IBD children.

Authors:  Francois-Pierre Martin; Ming-Ming Su; Guo-Xiang Xie; Seu Ping Guiraud; Martin Kussmann; Jean-Philippe Godin; Wei Jia; Andreas Nydegger
Journal:  World J Gastroenterol       Date:  2017-05-28       Impact factor: 5.742

5.  Pyroglutamic acidosis by glutathione regeneration blockage in critical patients with septic shock.

Authors:  Yenifer Gamarra; Felipe C Santiago; Jorge Molina-López; José Castaño; Lourdes Herrera-Quintana; Álvaro Domínguez; Elena Planells
Journal:  Crit Care       Date:  2019-05-07       Impact factor: 9.097

6.  Metabolic Profiling Reveals Effects of Age, Sexual Development and Neutering in Plasma of Young Male Cats.

Authors:  David Allaway; Matthew S Gilham; Alison Colyer; Thomas J Jönsson; Kelly S Swanson; Penelope J Morris
Journal:  PLoS One       Date:  2016-12-12       Impact factor: 3.240

7.  HIV-1 Envelope Protein gp120 Promotes Proliferation and the Activation of Glycolysis in Glioma Cell.

Authors:  Gabriel Valentín-Guillama; Sheila López; Yuriy V Kucheryavykh; Nataliya E Chorna; Jose Pérez; Jescelica Ortiz-Rivera; Michael Inyushin; Vladimir Makarov; Aníbal Valentín-Acevedo; Alfredo Quinones-Hinojosa; Nawal Boukli; Lilia Y Kucheryavykh
Journal:  Cancers (Basel)       Date:  2018-09-01       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.